ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1829

Multiomic Investigation of Juvenile Idiopathic Arthritis Synovium Reveals Immune Cell Heterogeneity

Abigail Thielbar1, Tracy Ting2, Lexi Auld3, Kelly Rogers4, Megan Quinlan-Waters5, Sheila Angeles-Han4, Ekemini Ogbu2, Daniel Lovell2, Jennifer Huggins6, Grant Schulert2, Patricia Vega-Fernandez2 and Yuriy Baglaenko4, 1Cincinnati Children's Hospital, Cincinnati, 2Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Cincinnati Children's Hospital Medical Center, Division of Rheumatology, Cincinnati, OH, 4Cincinnati Children's Hospital, Cincinnati, OH, 5Cincinnati Children's Hospital Medical Center, CCHMC, 6Cincinnati Children's Medical Center, Cincinnati, OH

Meeting: ACR Convergence 2025

Keywords: genomics, immunology, Juvenile idiopathic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1809–1829) Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common chronic inflammatory rheumatic disease of childhood, affecting 1:1,000 children worldwide. The hallmark of JIA is immune-mediated chronic inflammation in the synovium – clinically reflected by the presence of arthritis or a combination of joint pain, swelling, or limitation of joint movement. If inadequately treated, JIA can lead to profound lifelong joint deformity and disability. Thus, early diagnosis and treatment initiation is essential in the management of patients with JIA. Histological examination of synovium, although limited in scope, has identified immune cell infiltration of lymphocytes, plasma cells, macrophages as well as proliferation of fibroblast- and macrophage-like synoviocytes. To date, no comprehensive studies of JIA synovium have been performed as current best-practices do not routinely collect tissue biopsies for diagnosis or analysis. Recent single cell methodologies that assay open chromatin and transcriptome have made great strides in bridging this gap in adult rheumatic conditions by directly examining the synovium. The objective of this study is to leverage novel multiomic single cell strategies to characterize cell heterogeneity in the synovium of children with JIA.

Methods: Ultrasound guided synovial biopsies were performed in two children to isolate synovium. Tissue was enzymatically digested, sorted for viability, nuclei isolated, and single cell libraries generated with the 10X multiome (RNA + ATAC) pipeline. A PBMC sample from a JIA patient was also included to define tissue enrichment. Data was aligned with cellranger and processed with custom analysis pipelines.

Results: We obtain high quality data from three samples for single cell RNA and ATAC sequencing with a median of 1350 genes and 6233 ATAC peaks from 5771 cells. Integration of gene expression and open chromatin data, harmonization by donor, and clustering identifies 11 broad populations including T, B and fibroblasts cells. Comparison between tissue and blood sample identifies an enrichment of activated/memory CD4 and CD8 T cells and a decrease in monocytes populations specific to the synovium. Pathogenic HLA-DR+ fibroblasts are exclusively identified in synovium. Fine-grained analysis of T cells with our recently developed T cell annotation program (TCAT) identifies evidence of proliferation in Tfh/Tph and T regulatory cells.

Conclusion: To our knowledge, this is the first multiomic single cell study of JIA synovium that simultaneously captures gene expression and open chromatin. We implement a high-quality processing pipeline and identify cell heterogeneity specific to the synovium. In particular, we find evidence of immune cell activation and proliferation in Tfh/Tph and T regulatory cells from synovium.


Disclosures: A. Thielbar: None; T. Ting: None; L. Auld: None; K. Rogers: None; M. Quinlan-Waters: None; S. Angeles-Han: None; E. Ogbu: Cartesian Therapeutics, 2; D. Lovell: AbbVie, 2, Bristol-Myers Squibb(BMS), 2, Canadian Arthritis Society, 12, DSMB memberNIH-NIAMS and NIAID, Canadian Arthritis Society, Novartis, 2; J. Huggins: None; G. Schulert: IpiNovoyx, 5, Novartis, 2, SOBI, 2; P. Vega-Fernandez: None; Y. Baglaenko: None.

To cite this abstract in AMA style:

Thielbar A, Ting T, Auld L, Rogers K, Quinlan-Waters M, Angeles-Han S, Ogbu E, Lovell D, Huggins J, Schulert G, Vega-Fernandez P, Baglaenko Y. Multiomic Investigation of Juvenile Idiopathic Arthritis Synovium Reveals Immune Cell Heterogeneity [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/multiomic-investigation-of-juvenile-idiopathic-arthritis-synovium-reveals-immune-cell-heterogeneity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multiomic-investigation-of-juvenile-idiopathic-arthritis-synovium-reveals-immune-cell-heterogeneity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology